Publications by authors named "Unenbat Gurbadam"
Hepatocellular carcinoma (HCC) is one of the most common cancers occurring worldwide, including Mongolia. Although alpha-fetoprotein (AFP) is a widely used marker for HCC, conflicting studies have been published regarding its specificity and sensitivity towards HCC. Glypican-3 (GPC3) is a different promising biomarker for HCC, and there is some evidence to suggest that this protein may be a more specific marker compared with AFP.
View Article and Find Full Text PDFArticle Synopsis
- Adjuvant therapy (AT) has been shown to extend survival in pancreatic ductal adenocarcinoma patients, but its effects on invasive intraductal papillary mucinous neoplasms (IPMN) are unclear due to lack of guidelines.
- A study involving 332 patients across 15 centers analyzed the impact of AT on survival in resected invasive IPMN, revealing that disease-free survival was better in the surgery-only group compared to the AT group, although overall survival rates were similar.
- The findings suggest that AT may not provide a survival benefit for resected invasive IPMN patients, particularly in stages I and II, indicating the need for further research on the role of AT in this context.